biogenex-laboratories-blog

[biogenex-laboratories-blog]

NanoVIP® 300 – All-in-One Fully Automated System for FISH, ISH, IHC

NanoVIP® 300 are diverse, fully automated barcoded systems for fluorescence in situ hybridization (FISH), in situ hybridization (ISH), miRNA ISH, and IHC. Its reliable automation combined with eXACT™ temperature modules, predefined protocols, and liquid level sensors for accurate liquid handling ensures robust and reproducible results.

[biogenex-laboratories-blog]

A microwave-based antigen retrieval system invented by BioGenex

The EZ-Retriever® IR System by BioGenex is a microwave-based antigen retrieval system designed for FFPE tissue sections, ensuring epitope accessibility and high-quality, reproducible staining. With adjustable power, volume, and heating time, it eliminates inconsistencies in retrieval methods. This user-friendly, high-throughput system processes 96 slides in 30 minutes, standardizing protocols for optimal results. For best performance, use with our EZ-AR™ Elegance retrieval solutions.

Learn More : https://biogenex.com/ez-rt-system/

[biogenex-laboratories-blog]

Unlocking Precision and Efficiency: The Benefits of Automated Slide-Staining Systems in Tumor Diagnosis

Introduction

In the realm of modern medicine, precision and efficiency are paramount, especially when it comes to diagnosing complex conditions like tumors. Traditional diagnostic methods, although effective, can be time-consuming and prone to human error. This is where automated slide-staining systems come into play. These advanced technologies have revolutionized tumor diagnosis, offering a host of benefits that enhance accuracy, streamline processes, and ultimately improve patient outcomes.

Enhanced Accuracy

One of the primary advantages of automated slide-staining systems in tumor diagnosis is their ability to provide consistent and accurate results. Human errors, such as variations in staining techniques or misinterpretation of slides, can lead to incorrect diagnoses. Automated systems, on the other hand, ensure uniform staining procedures and eliminate the risk of human error, leading to more reliable results.

Time Efficiency

Manual staining of slides for tumor diagnosis can be a labor-intensive and time-consuming process. Automated systems dramatically reduce the time required for staining, allowing for quicker turnaround times in pathology labs. This rapid processing not only expedites diagnosis but also facilitates timely treatment decisions, which can be critical in cancer cases.

Standardization of Processes

Consistency is key in pathology, and automated slide-staining systems excel in standardizing staining protocols. These systems can be programmed to follow precise staining procedures, ensuring that each slide is treated identically. This consistency minimizes inter-laboratory variability and enhances the reproducibility of results, which is essential for research studies and clinical trials.

Preservation of Sample Integrity

Preserving the integrity of tissue samples is crucial in tumor diagnosis. Manual staining techniques may subject samples to handling errors or contamination. Automated systems handle samples with care, reducing the risk of damage or contamination and preserving the sample's quality.

Cost-Efficiency

While automated slide-staining systems represent a significant initial investment, they often prove cost-effective in the long run. The reduced need for manual labor and the elimination of reagent waste due to precise, controlled staining contribute to cost savings over time. Additionally, the ability to process a higher volume of slides with fewer resources makes automated systems economically viable for high-throughput laboratories.

Improved Workflow

Streamlining the diagnostic process is a key benefit of automation. Automated slide-staining systems can be seamlessly integrated into laboratory workflows, reducing bottlenecks and optimizing resource allocation. This allows pathologists to focus more on interpretation and less on tedious, time-consuming tasks.

Flexibility and Customization

Modern automated systems offer a high degree of flexibility and customization. Laboratories can adapt staining protocols to suit specific diagnostic needs or accommodate different types of specimens. This adaptability ensures that the system can address a wide range of tumor diagnosis requirements.

Conclusion

The adoption of automated slide-staining systems like NanoVIP® has ushered in a new era of precision and efficiency in tumor diagnosis. By enhancing accuracy, reducing processing times, standardizing procedures, and preserving sample integrity, these systems contribute significantly to improved patient care and outcomes. As technology continues to advance, the benefits of automation in pathology will only become more pronounced, reinforcing the vital role that automated slide-staining systems play in the field of medicine.

[biogenex-laboratories-blog]

BioGenex is an American diagnostic company established in 1981 in San Ramon, CA with a mission to provide affordable solutions for life science research and personalized medicine.

BioGenex designs, develops, and commercializes automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The company offers a range of slide-based tissue and cell staining products to support assay development for clinical diagnosis and translational research. The product range includes a wide variety of primary antibodies, high sensitive detection kits, automated systems, probes, antigen retrieval systems, and histology stains. BioGenex prides itself on delivering innovative products, years ahead of the competition in the field of immunohistochemistry (IHC) and in situ hybridization (ISH). BioGenex holds a strong intellectual portfolio with the several US and foreign-issued patents.

BioGenex offers a broad range of slide-based tissue staining products to support assay development in translational research and clinical diagnosis of cancers for molecular pathology labs. Some of these applications include:

Immunohistochemistry (IHC) – total automation and walkway solution including – instruments, primary antibodies, detection system and reagents for the localization of antigen within a cell or a tissue preparation of various types.

in situ hybridization (ISH) - for precise detection and localization of a specific nucleic acid sequence within a histologic section. Our ISH solution covers automated instruments, systems, along with probes, detection systems, ancillaries and nucleic acid retrieval system.

Fluorescent in situ hybridization (FISH) - to check for genetic abnormalities associated with prenatal diagnosis, cancer, birth defects, and mental retardation. Our BioGenex FISH offerings includes industry-first total FISH automation systems along with probes and detection kits.

microRNA ISH – We caters specialize Biomarker miRNA Probe panels for characterization of CUP and poorly differentiated tumors with an industry first extensive list of 235 probes. Our miRNA probes integrate seamlessly with our automation solutions.

BioGenex also provide solutions for multiplexing, special staining, in situ PCR and specialized antigen retrieval systems.

BioGenex automated solutions streamline operations for cellular pathology laboratories worldwide. BioGenex operates in 80+ countries across the globe directly and through distributors. BioGenex is headquartered in Fremont, California and has two major manufacturing sites in Fremont, California and Hyderabad, India. The organization has a Centre of Excellence in Hyderabad, providing training for domestic and international customer and distributors. The organization also has a regional sales office in Shanghai, China, and Milan, Italy.

https://www.biogenex.com